Results 81 to 90 of about 4,399 (136)

Extracellular vesicles in Graves' disease and Graves' orbitopathy: immunoregulatory mechanisms, biomarkers, and therapeutic potentials. [PDF]

Front Immunol
Chen Y, Yang Y, Yang S, Yuan W, Jiang L, Wei R.   +5 more
europepmc   +1 more source

Therapeutic targets for fibro-inflammation in Graves' orbitopathy. [PDF]

Taiwan J Ophthalmol
Kang YJ, Yoon JS.
europepmc   +1 more source

Pediatric Graves' orbitopathy: TRAb and FT-3 are also prognostic factors in children-A tertiary center study. [PDF]

Thyroid Res
Al-Ghazzawi K, Oeverhaus M, Rama A, Kiewert C, Bechrakis N, Chen Y, Neumann I, Eckstein A.   +7 more
europepmc   +1 more source

Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy. [PDF]

Eur Thyroid J
Bartalena L, Gallo D, Kahaly GJ, Marinò M, Tanda ML.   +4 more
europepmc   +1 more source

Higher serum IgG4 levels correlate with better quality of life in mild Graves' orbitopathy: a preliminary report. [PDF]

Endocr Connect
Lin CH, Lee YC, Hsiue YC, Wei YH, Lee CW, Yang CY, Fan KC, Yen IW, Lu C, Huang TY, Lin CH, Shih SR.   +11 more
europepmc   +1 more source

Graves' orbitopathy following Alemtuzumab treatment for multiple sclerosis: a systematic review and real-world insights. [PDF]

Thyroid Res
Patera B, Zaffaroni A, Louka S, Gallo D, Piantanida E, Tanda ML.   +5 more
europepmc   +1 more source

Pure Endoscopic Orbital Decompression in Graves' Orbitopathy: A Comprehensive Retrospective Analysis of Objective and Subjective Outcomes. [PDF]

Med Sci (Basel)
Almanzo S, Saro-Buendía M, Tortajada-Torralba I, Peris-Moreno C, España-Gregori E, Armengot M, García-Piñero A.   +6 more
europepmc   +1 more source

Real world effectiveness of Mycophenolate-sodium therapy in patients at risk with Graves' orbitopathy. [PDF]

Thyroid Res
Sander J, Al-Ghazzawi K, Bechrakis N, Chen Y, Neumann I, Eckstein A, Oeverhaus M.   +6 more
europepmc   +1 more source

Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression.

J Clin Endocrinol Metab
Lanzolla G, Saba F, Corrias S, Lixi F, Faa G, Colleo A, Mura C, Canu GL, Cappellacci F, Cuccu A, Giannaccare G, Mariotti S, Boi F.   +12 more
europepmc   +1 more source

Risk factors and outcomes of Graves' orbitopathy after radioactive iodine therapy. [PDF]

Endocrine
Ahn HY, Lee J, Kim M, Lee JK.
europepmc   +1 more source